SOLV

NYSE

Solventum Corp

Health Care, Health Care Technology

$82.98

close 7 Aug 2026

+15.47%

52-week change

$14.12B

market cap

$62.38

$90.00

52-week range

Expected price

$80.73 – $98.66

Current price

$82.98

Signal

Appears fairly valued

A historical-multiple reference, never a fair-value claim. The band uses only data public at each date and ends at the latest month — no forward estimates.

Current multiples

P/E (TTM)10.13x

P/S (TTM)1.70x

P/B2.94x

EV/EBITDA (TTM)7.31x

FCF yield (TTM)-0.84%

PEG (TTM, GAAP)2.25

Context

P/E, own 5-year average16.77x

P/E, sector median29.65x*

Price at 5-year median P/E$92.02*

Forward — analyst consensus

Forward P/E (FY2026)11.54x*

Forward P/E (FY2027)11.54x

Forward PEG314.32*

Consensus EPS FY2026 (12 analysts)$7.19

EPS growth (FY2026→FY2027)0.04%

Revenue growth (FY2026)-1.24%

Street view

Price target (mean)$93.15*

Target upside12.26%

Ratings (buy / hold / sell)8 / 5 / 2

FY2026 EPS revisions, 30d (up / down)0 / 3

5-year history

Dashed line: average of month-end values

P/E (TTM)

P/S (TTM)

P/B

FCF yield (TTM)

period to 30 Jun 2026, filed 5 Aug 2026, close 7 Aug 2026

Discounted cash flow

Ten projected years plus a perpetuity, prefilled from filings — a model to argue with, never a fair-value claim.

Free cash flow, last ten years and TTM

Assumptions

Growth rate, years 1–10%

Perpetual growth%Discount rate%

Base FCF$M

As filed — not assumptions

Current price$82.98

Cash & equivalents$403.00M

Total debt$5.08B

Shares outstanding170.11M

Result

DCF price per share-$43.20

Current price$82.98

Margin of safety-152.06%

PV of years 1–10-$1.01B

PV of terminal value-$1.66B

Equity value-$7.35B

Market-implied growth—

The base free cash flow is not positive; growing a negative flow is rarely a meaningful valuation.

Projected FCF, years 1–10

Hover for PV and growth

Projection detail

Override growth for any year; blank years use the uniform rate

Year	2026	2027	2028	2029	2030	2031	2032	2033	2034	2035	Terminal
Growth, %											2.5
FCF	-$123.90M	-$130.10M	-$136.60M	-$143.43M	-$150.60M	-$158.13M	-$166.04M	-$174.34M	-$183.06M	-$192.21M	-$3.58B
PV	-$114.72M	-$111.54M	-$108.44M	-$105.43M	-$102.50M	-$99.65M	-$96.88M	-$94.19M	-$91.57M	-$89.03M	-$1.66B

period to 30 Jun 2026, filed 5 Aug 2026, close 7 Aug 2026